Unpublished data shows breast cancer drug 'third less effective' (Guardian, 16 May 2008)

Boston Scientific Corporation (BSX) Release: TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program (Biospace, 13 May 2008)

16 May 2008

Results from an analysis of 7,500 patients from Boston Scientific Corporation's TAXUS ARRIVE registries were presented at the annual EuroPCR Scientific Program in Barcelona.

Full article

Boston Scientific Corporation (BSX) Release: TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program (Biospace, 13 May 2008)

Share this story

Top stories

Most read